Health Care: Health Services

Antares Pharma Inc. (ATRS: NASDAQ)

$4.06 0.08 | 2.01%
05/17/13 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 4.06
52 Week High 5.58
52 Week Low 2.60
Avg. Daily Vol. (Mil) 0.94
Beta (3 year) 0.32
Share Related Items
Mkt Cap (Mil) 512.27
Shares Out (Mil) 126.18
Float (Mil) 112.72
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.00
Current Ratio 11.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 25.31
Price/Book 6.13
Price/Cash Flow -35.10
Per Share Data
Earnings -0.13
Sales 0.16
Book Value 0.66
Cash Flow -0.12
Business Summary
Antares Pharma, Inc., is a specialty pharmaceutical company developing and commercializing self-administered parenteral pharmaceutical products and technologies and topical gel-based products. Its products include OTREXUP and Medi-Jet.
General Information
100 Princeton South
Suite 300
Ewing, NJ 08628
www.antarespharma.com
Industry : Health Services
Sector: Health Care
Employees: 42
CEO: Dr. Paul K. Wotton,PhD
Short Interest
Current Month (Mil) 10.87
Previous Month (Mil) 10.99
Short Interest Ratio (Days) 11.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -16.30
Return on Investments -17.00
Profitability
Gross Margin 54.10
EBIT Margin -72.90
Profit Margin -73.30

Portfolios with ATRS

View All

Latest ATRS Headlines from TheStreet

More Financial News for ATRS

Press Releases for ATRS

See All Press Releases

Partner Headlines for ATRS

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter